MBP metabolic pharmaceuticals limited

glad i got the 82, page-6

  1. 6,010 Posts.
    re: fin review: worst in asx 300 last week The risk is always there, no matter which company. But in MBP's case investors should have been warned over the last 3 years by deadline promises for trials which were not kept, ambiguously worded announcements, and the inability of the management to keep things moving.
    Incompentence at its best ( or worst).
    You all can read, and if wishful thinking overrules your logic, thats your problem then. Don't trade. Punt on horses.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.